80 FR 72077 - Proposed Collection; 60-Day Comment Request; The National Physician Survey of Precision Medicine in Cancer Treatment (NCI)
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health Federal Register Volume 80, Issue 222 (November 18, 2015)
National Institutes of Health
Federal Register Volume 80, Issue 222 (November 18, 2015)
| Page Range | 72077-72078 | |
| FR Document | 2015-29382 |
[Federal Register Volume 80, Number 222 (Wednesday, November 18, 2015)] [Notices] [Pages 72077-72078] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-29382] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; 60-Day Comment Request; The National Physician Survey of Precision Medicine in Cancer Treatment (NCI) Summary: In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Cancer Institute, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited to address one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) The quality, utility, and clarity of the information to be collected; and (4) Minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments and For Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Janet S. de Moor, Ph.D., MPH, Project Officer, Division of Cancer [[Page 72078]] Control and Population Sciences, 9609 Medical Center Drive, 3E438, MSC 9764, Rockville, MD, 20850 or call non-toll-free number 240-276-6806 or Email your request, including your address to: [email protected]. Formal requests for additional plans and instruments must be requested in writing. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: The National Physician Survey of Precision Medicine in Cancer Treatment 0925-NEW, National Cancer Institute (NCI), National Institutes of Health (NIH). Need and Use of Information Collection: The purpose of this study is to investigate the current practice of precision medicine in cancer treatment among medical oncologists in the U.S. This is a nationally representative survey designed to assess oncologists' current and potential use of genomic testing, to inform the development of interventions to facilitate optimal use of genomic testing and to improve patient-physician discussions of the risks, possible benefits, and uncertainties surrounding the use of these tests. Current knowledge of this topic is limited as there are no nationally-representative studies on this topic to date. There are only two non-federal studies two that have examined physicians' knowledge and attitudes regarding somatic genetic and genomic testing. The survey will be administered by mail and web to approximately 1,630 oncology physicians across the U.S. Non-respondents will be invited to complete a follow-back survey to share their reasons for not participating. The study findings will inform NCI of relevant issues and concerns relating to the application of precision medicine to current and future cancer treatment patterns and practice. This information will also inform the development of new funding initiatives to optimize the use of precision medicine in cancer treatment. Additionally, information collected as part of this survey will be used to develop physician educational materials to address barriers to precision medicine in cancer care delivery. OMB approval is requested for 2 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 261. Estimated Annualized Burden Hours ---------------------------------------------------------------------------------------------------------------- Number of Average burden Form name Type of Number of responses per per response Total annual respondent respondents respondent (in hours) burden hour ---------------------------------------------------------------------------------------------------------------- Precision Medicine Survey-- Oncology 175 1 20/60 58 Pilot Study. Physicians. Precision Medicine Survey-- Oncology 600 1 20/60 200 Full Study. Physicians. Follow-back Survey............ Oncology 40 1 5/60 3 Physicians. ---------------------------------------------------------------------------------------------------------------- Dated: October 28, 2015. Karla Bailey, Project Clearance Liaison, NCI, NIH. [FR Doc. 2015-29382 Filed 11-17-15; 8:45 am] BILLING CODE 4140-01-P
![Federal Register / Vol. 80, No. 222 / Wednesday, November 18, 2015 / Notices 72077
Date: December 3, 2015. Name of Committee: Center for Scientific Institute of Child Health and Human
Time: 1:00 p.m. to 4:00 p.m. Review Special Emphasis Panel, PAR Panel: Development, NIH, 6100 Executive
Agenda: To review and evaluate grant Global Infectious Diseases Research Training Boulevard, Room 5B01, Bethesda, MD
applications. Program. 20892–9304, (301) 435–6898, wallsc@
Place: National Institutes of Health, 6100 Date: December 11, 2015. mail.nih.gov.
Executive Boulevard, Rockville, MD 20852, Time: 8:00 a.m. to 6:00 p.m. (Catalogue of Federal Domestic Assistance
(Telephone Conference Call). Agenda: To review and evaluate grant Program Nos. 93.864, Population Research;
Contact Person: Sathasiva B. Kandasamy, applications. 93.865, Research for Mothers and Children;
Ph.D., Scientific Review Officer, Scientific Place: The St. Regis Washington, DC, 923 93.929, Center for Medical Rehabilitation
Review Branch, National Institute of Child 16th Street NW., Washington, DC 20006. Research; 93.209, Contraception and
Health and Human Development, 6100 Contact Person: Hilary D Sigmon, Ph.D., Infertility Loan Repayment Program, National
Executive Boulevard, Room 5B01, Bethesda, Scientific Review Officer, Center for Institutes of Health, HHS)
MD 20892–9304, (301) 435–6680, Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216, Dated: November 12, 2015.
skandasa@mail.nih.gov.
MSC 7852, Bethesda, MD 20892, (301) 594– Michelle Trout,
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research; 6377, sigmonh@csr.nih.gov. Program Analyst, Office of Federal Advisory
93.865, Research for Mothers and Children; (Catalogue of Federal Domestic Assistance Committee Policy.
93.929, Center for Medical Rehabilitation Program Nos. 93.306, Comparative Medicine; [FR Doc. 2015–29376 Filed 11–17–15; 8:45 am]
Research; 93.209, Contraception and 93.333, Clinical Research, 93.306, 93.333, BILLING CODE 4140–01–P
Infertility Loan Repayment Program, National 93.337, 93.393–93.396, 93.837–93.844,
Institutes of Health, HHS) 93.846-93.878, 93.892, 93.893, National
Institutes of Health, HHS)
DEPARTMENT OF HEALTH AND
Dated: November 12, 2015. Dated: November 10, 2015. HUMAN SERVICES
Michelle Trout, Sylvia Neal,
Program Analyst, Office of Federal Advisory Program Analyst, Office of Federal Advisory National Institutes of Health
Committee Policy. Committee Policy.
[FR Doc. 2015–29377 Filed 11–17–15; 8:45 am] Proposed Collection; 60-Day Comment
[FR Doc. 2015–29381 Filed 11–17–15; 8:45 am]
BILLING CODE 4140–01–P Request; The National Physician
BILLING CODE 4140–01–P
Survey of Precision Medicine in
Cancer Treatment (NCI)
DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND Summary: In compliance with the
HUMAN SERVICES HUMAN SERVICES requirement of Section 3506(c)(2)(A) of
National Institutes of Health the Paperwork Reduction Act of 1995,
National Institutes of Health for opportunity for public comment on
Center for Scientific Review; Notice of proposed data collection projects, the
Eunice Kennedy Shriver National
Closed Meetings National Cancer Institute, the National
Institute of Child Health And Human
Institutes of Health (NIH) will publish
Development; Notice of Closed
Pursuant to section 10(d) of the periodic summaries of proposed
Meeting
Federal Advisory Committee Act, as projects to be submitted to the Office of
amended (5 U.S.C. App.), notice is Pursuant to section 10(d) of the Management and Budget (OMB) for
hereby given of the following meetings. Federal Advisory Committee Act, as review and approval.
The meetings will be closed to the amended (5 U.S.C. App.), notice is Written comments and/or suggestions
public in accordance with the hereby given of the following meeting. from the public and affected agencies
provisions set forth in sections The meeting will be closed to the are invited to address one or more of the
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., public in accordance with the following points: (1) Whether the
as amended. The grant applications and provisions set forth in section 552b(c)(4) proposed collection of information is
the discussions could disclose and 552b(c)(6), Title 5 U.S.C., as necessary for the proper performance of
confidential trade secrets or commercial amended. The grant applications and the function of the agency, including
property such as patentable material, the discussions could disclose whether the information will have
and personal information concerning confidential trade secrets or commercial practical utility; (2) The accuracy of the
individuals associated with the grant property such as patentable material, agency’s estimate of the burden of the
applications, the disclosure of which and personal information concerning proposed collection of information,
would constitute a clearly unwarranted individuals associated with the grant including the validity of the
invasion of personal privacy. applications, the disclosure of which methodology and assumptions used; (3)
would constitute a clearly unwarranted The quality, utility, and clarity of the
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PAR Panel:
invasion of personal privacy. information to be collected; and (4)
Fogarty HIV Research Training Program for Name of Committee: National Institute of Minimize the burden of the collection of
Low-and Middle-Income Country Child Health and Human Development information on those who are to
Institutions. Special Emphasis Panel; Maternal and Child respond, including the use of
Date: December 10, 2015. Health in Poor Countries: Evidence From appropriate automated, electronic,
Time: 8:00 a.m. to 6:00 p.m. Randomized Evaluation. mechanical, or other technological
Agenda: To review and evaluate grant Date: December 9, 2015. collection techniques or other forms of
asabaliauskas on DSK5VPTVN1PROD with NOTICES
applications. Time: 11:00 a.m. to 3:00 p.m. information technology.
Place: The St. Regis Washington, DC, 923 Agenda: To review and evaluate grant To Submit Comments and For Further
16th Street NW., Washington, DC 20006. applications. Information: To obtain a copy of the
Contact Person: Hilary D Sigmon, Ph.D., Place: Hyatt Regency Bethesda, One
Scientific Review Officer, Center for Bethesda Metro Center, 7400 Wisconsin
data collection plans and instruments,
Scientific Review, National Institutes of Avenue, Bethesda, MD 20814. submit comments in writing, or request
Health, 6701 Rockledge Drive, Room 5216, Contact Person: Carla T. Walls, Ph.D., more information on the proposed
MSC 7852, Bethesda, MD 20892, (301) 594– Scientific Review Officer, Scientific Review project, contact: Janet S. de Moor, Ph.D.,
6377, sigmonh@csr.nih.gov. Branch, Eunice Kennedy Shriver National MPH, Project Officer, Division of Cancer
VerDate Sep<11>2014 18:50 Nov 17, 2015 Jkt 238001 PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 E:\FR\FM\18NON1.SGM 18NON1](https://thefederalregister.org/doc/80_FR_72299/page/1.svg)
![72078 Federal Register / Vol. 80, No. 222 / Wednesday, November 18, 2015 / Notices
Control and Population Sciences, 9609 precision medicine in cancer treatment Non-respondents will be invited to
Medical Center Drive, 3E438, MSC among medical oncologists in the U.S. complete a follow-back survey to share
9764, Rockville, MD, 20850 or call non- This is a nationally representative their reasons for not participating. The
toll-free number 240–276–6806 or Email survey designed to assess oncologists’ study findings will inform NCI of
your request, including your address to: current and potential use of genomic relevant issues and concerns relating to
janet.demoor@nih.gov. Formal requests testing, to inform the development of the application of precision medicine to
for additional plans and instruments interventions to facilitate optimal use of current and future cancer treatment
must be requested in writing. genomic testing and to improve patient- patterns and practice. This information
Comment Due Date: Comments physician discussions of the risks, will also inform the development of
regarding this information collection are possible benefits, and uncertainties new funding initiatives to optimize the
best assured of having their full effect if surrounding the use of these tests. use of precision medicine in cancer
received within 60 days of the date of Current knowledge of this topic is treatment. Additionally, information
this publication. limited as there are no nationally- collected as part of this survey will be
Proposed Collection: The National representative studies on this topic to used to develop physician educational
Physician Survey of Precision Medicine date. There are only two non-federal materials to address barriers to precision
in Cancer Treatment 0925–NEW, studies two that have examined medicine in cancer care delivery.
National Cancer Institute (NCI), physicians’ knowledge and attitudes OMB approval is requested for 2
National Institutes of Health (NIH). regarding somatic genetic and genomic years. There are no costs to respondents
Need and Use of Information testing. The survey will be administered other than their time. The total
Collection: The purpose of this study is by mail and web to approximately 1,630 estimated annualized burden hours are
to investigate the current practice of oncology physicians across the U.S. 261.
ESTIMATED ANNUALIZED BURDEN HOURS
Average
Number of
Number of burden per Total annual
Form name Type of respondent responses per
respondents response burden hour
respondent (in hours)
Precision Medicine Survey—Pilot Oncology Physicians ........................ 175 1 20/60 58
Study.
Precision Medicine Survey—Full Oncology Physicians ........................ 600 1 20/60 200
Study.
Follow-back Survey ........................... Oncology Physicians ........................ 40 1 5/60 3
Dated: October 28, 2015. Name of Committee: National Institute of DEPARTMENT OF HEALTH AND
Karla Bailey, Allergy and Infectious Diseases Special HUMAN SERVICES
Emphasis Panel; Innovation for HIV Vaccine
Project Clearance Liaison, NCI, NIH.
Discovery (R01). National Institutes of Health
[FR Doc. 2015–29382 Filed 11–17–15; 8:45 am]
Date: December 10–11, 2015.
BILLING CODE 4140–01–P Time: 11:00 a.m. to 5:00 p.m. National Institute on Drug Abuse
Agenda: To review and evaluate grant Amended; Notice of Meeting
applications.
DEPARTMENT OF HEALTH AND Place: National Institutes of Health, Room Notice is hereby given of a change in
HUMAN SERVICES 3G61, 5601 Fishers Lane, Rockville, MD the meeting of the National Institute on
20892 (Telephone Conference Call). Drug Abuse Special Emphasis Panel,
National Institutes of Health Contact Person: Jane K. Battles, Ph.D., November 13, 2015, 01:00 p.m. to
Scientific Review Officer, Scientific Review November 13, 2015, 05:00 p.m.,
National Institute of Allergy and Program, Division of Extramural Activities,
Infectious Diseases; Notice of Closed National Institutes of Health,
Room # 3F30B, National Institutes of Health/
Meeting Neuroscience Center, 6001 Executive
NIAID, 5601 Fishers Lane, MSC 9823,
Bethesda, MD 20852–9823, (240) 669–5029,
Boulevard, Rockville, MD, 20852 which
Pursuant to section 10(d) of the battlesja@mail.nih.gov. was published in the Federal Register
Federal Advisory Committee Act, as on October 22, 2015, 80 FR 64428.
(Catalogue of Federal Domestic Assistance
amended (5 U.S.C. App.), notice is The date of the meeting was changed
Program Nos. 93.855, Allergy, Immunology,
hereby given of the following meeting. to December 1, 2015. The meeting is
and Transplantation Research; 93.856,
The meeting will be closed to the Microbiology and Infectious Diseases closed to the public.
public in accordance with the Research, National Institutes of Health, HHS) Dated: November 12, 2015.
provisions set forth in sections
Dated: November 12, 2015. Natasha Copeland,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and Natasha Copeland, Program Analyst, Office of Federal Advisory
asabaliauskas on DSK5VPTVN1PROD with NOTICES
the discussions could disclose Program Analyst, Office of Federal Advisory Committee Policy.
confidential trade secrets or commercial Committee Policy. [FR Doc. 2015–29379 Filed 11–17–15; 8:45 am]
property such as patentable material, [FR Doc. 2015–29380 Filed 11–17–15; 8:45 am] BILLING CODE 4140–01–P
and personal information concerning BILLING CODE 4140–01–P
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014 18:50 Nov 17, 2015 Jkt 238001 PO 00000 Frm 00039 Fmt 4703 Sfmt 9990 E:\FR\FM\18NON1.SGM 18NON1](https://thefederalregister.org/doc/80_FR_72299/page/2.svg)
Document Created: 2018-03-01 11:20:24
Document Modified: 2018-03-01 11:20:24
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | Comments regarding this information collection are best assured of having their full effect if received within 60 days of the date of this publication. | |
| FR Citation | 80 FR 72077 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR